Showing results (971-980 of 1,277) with videos related to

Sort By:
Pageof 128
Dalton Transactions (Cambridge, England : 2003)|October 11, 2016
Structure and thermodynamic stability of UTa<sub>3</sub>O<sub>10</sub>, a U(v)-bearing compoundXiaofeng Guo, Christian Lipp, Eitan Tiferet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 1, 2014
Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013L M Shulman, E Gavrilin, J Jorba, et al.
The American Journal of Otology|November 1, 1992
Audiologic profiles of children with Kawasaki diseaseR P Sundel, S S Cleveland, A S Beiser, et al.
Best Practice & Research. Clinical Anaesthesiology|December 4, 2019
Truncal regional nerve blocks in clinical anesthesia practiceIvan Urits, Peter S Ostling, Matthew B Novitch, et al.
Viruses|April 3, 2021
Environmental Surveillance for Polioviruses in Haïti (2017-2019): The Dynamic Process for the Establishment and Monitoring of Sampling SitesMary M Alleman, Angela D Coulliette-Salmond, Pierre Wilnique, et al.
Hypertension (Dallas, Tex. : 1979)|May 17, 2024
Sex-Dependency of T Cell-Induced Salt-Sensitive Hypertension and Kidney DamageJustine M Abais-Battad, John Henry Dasinger, Hayley Lund, et al.
International Journal of Clinical and Health Psychology : IJCHP|November 30, 2018
A case-controlled field study evaluating ICD-11 proposals for relational problems and intimate partner violenceRichard E Heyman, Cary S Kogan, Heather M Foran, et al.
The Pediatric Infectious Disease Journal|September 24, 2015
Axillary, Oral and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki DiseaseJohn T Kanegaye, Jefferson M Jones, Jane C Burns, et al.
Vaccine|February 25, 2020
Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patientsSharla L McDonald, William C Weldon, Ling Wei, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|May 30, 2025
A phase I/IIa trial of atorvastatin in Japanese patients with acute Kawasaki disease and coronary artery aneurysmsKenji Furuno, Eisuke Suganuma, Hiroshi Masuda, et al.
Pageof 128